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Chromosome replication as a 
measure of bacterial growth rate 
during Escherichia coli infection in 
the mouse peritonitis model
Maria Schei Haugan1,2, Godefroid Charbon  1, Niels Frimodt-Møller2 & Anders Løbner-Olesen1
The efficacy of most antibiotics is dependent on active bacterial growth, yet little is known about the 
growth dynamics during infection. Therefore, means to measure in-host bacterial growth rate is of 
importance. Here, we use chromosome replication as readout for in situ bacterial growth rate during 
infection; obtained from a single biological specimen. We have applied two independent methods: 
quantitative PCR (qPCR) and fluorescence microscopy, to quantify the level of chromosome replication 
present during Escherichia coli propagation in the mouse peritonitis model. We find that the methods 
complement each other and allow for quantification of growth rate, both on a population average and 
on a single-cell level. We demonstrate the presence of heterogeneous growth rates within bacterial 
populations propagating during infection. Also, no growth cessation was observed during the apparent 
stationary phase in vivo, and, by comparison of growth dynamics at different anatomical sites, we 
demonstrate that E. coli is unlikely to grow independently intravascularly. These findings provide novel 
insight into bacterial growth during host infection, and underscore the importance of pinpointing the 
primary site of infection in septicaemia of unknown origin and ensuring antibiotic availability at this site.
The interplay between bacterial growth and chromosome replication has been studied extensively under labo-
ratory conditions for decades1–6. Until recent years, the detection of chromosome replication status in bacteria 
propagating in their natural host (in vivo) had received scant attention. Bacterial growth in vivo has generally 
been assessed by viable bacterial counts (colony forming units (CFU)/ml)) plotted as a function of time. In a 
batch culture with a finite amount of nutrients, this curve is divided into well-defined growth phases7. However, 
bacterial growth dynamics in vivo are complex; growth rate is not solely a function of nutrient availability, but 
also of host immune-mediated clearance8–11. Applying bacterial count measurements to deduce an absolute bac-
terial growth rate in vivo is therefore not adequate, as this merely reflects the net change in bacterial population 
size. Neither does it reflect the level of growth rate heterogeneity within the population. To circumvent some of 
these limitations, recently published studies have explored the use of chromosome replication status as readout 
for bacterial growth rate in environmental and human microbiomes and found good correlation between the 
two12–14. However, this was achieved by whole genome sequencing, a method that besides being expensive and 
time-consuming, only provides a population average readout and fails to provide information on any possible 
differential growth rates within the population.
Escherichia coli, like many other bacteria, possesses one circular chromosome. DNA replication is initiated 
from a single origin of replication (oriC) and carried out bidirectionally, terminating in the opposite replication 
terminus region (terC)1,2,15,16. Coordination between chromosome replication and cell division ensures that the 
two identical daughter cells accommodate at least one fully replicated chromosome17,18. Initiation of replication 
takes place at a fixed cell mass per origin: the initiation mass3,19–22. Under favourable growth conditions multiple 
rounds of synchronously initiated replications per division cycle can occur4,23. This allows for faster growth rates, 
with daughter cells carrying chromosomes with overlapping rounds of replication, i.e. more than one number 
of oriC copies (2n, n = 1, 2, 3), at birth. Due to the consistency of the initiation mass, rapidly growing cells har-
bouring overlapping rounds of replication have larger cell mass proportional to the number of oriC copies. The 
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growth rate of the population is reflected by the copy number ratio of oriC to terC (ori:ter), with an ori:ter of 1 
representing non-replicating cells carrying a complete set of chromosome(s) and an ori:ter > 1 representing 
cells with ongoing chromosome replication (growing cells)1,24. Theoretically, this correlation can be expressed as 
ori:ter = 2 C/τ (1), where C is the chromosome replication time (C-period) and τ is the mass doubling time, and 
thus τ = C/log2(ori:ter) (2)24. However, such an unambiguous measure can only be inferred from a population of 
bacterial cells propagating at balanced growth rates, and only at τ < approximately 60 minutes, where C has been 
shown to be constant25.
Here, we applied quantitative PCR (qPCR), an inexpensive and easily accessible method, to provide popu-
lation average measurements of bacterial growth rates during infection in vivo, combined with chromosomal 
fluorescent marker frequency analysis for quantification of bacterial growth at a single-cell level. The goal was to 
determine variation in in situ bacterial growth rates at various anatomical sites, which would add to our current 
understanding of growth dynamics during infection. We hypothesized that growth dynamics within and outside 
the primary site of infection would be different. Furthermore, the detection of an in situ bacterial growth rate 
obtained from one single specimen could form the basis for refining future antibacterial strategies, knowing that 
the efficacy of most antibiotics in clinical use is related to active bacterial growth26,27.
Results
Two methods for detection of ori:ter were tested in vivo in an experimental murine infection model; qPCR, where 
the ori:terqPCR was given as a population mean, and fluorescence microscopy, where the ori:termic was deduced 
from direct analysis of single fluorescently labelled live bacterial cells (exemplified in Fig. 1, where oriC foci 
are displayed in green (GFP labelling) and terC foci are displayed in red (mCherry labelling)). In ori:terqPCR the 
‘oriC’ copy number was inferred from a site located immediately to the left of oriC, and the ‘terC’ copy num-
ber was inferred from a site located in close proximity to terC28. We applied these methods, in combination 
with bacterial counts, to reveal fundamental bacterial growth dynamics at various anatomical sites during infec-
tion. Furthermore, the correlation between cell length (µm) (measured by microscopy and used as a proxy for 
cell mass) and oriC/cell was measured to investigate initiation mass consistency during infection in vivo. As 
proof-of-concept, the same methods were tested and validated in vitro, using the same model infective organism; 
Escherichia coli ATCC® 25922™.
Bacterial growth in vitro. Bacteria grown in vitro in Lysogeny Broth (LB) batch cultures were used to val-
idate the methods applied in the in vivo experiments. Here, stationary phase bacterial cells were diluted in fresh 
media and allowed to grow with repeated sample collections at time points 2, 4, 6, 8 and 10 hours of incubation. 
As a complete cessation of growth was observed at 10 hours of incubation, the in vitro experiments were not 
extended beyond this time point. We tested the wild-type strain (ATCC 25922) alongside a genetically modified 
derivative of the strain, with chromosomally incorporated fluorescent oriC and terC labels (ALO 4783). This was 
done to ensure that transgene insertion would not affect growth dynamics of the derivative strain, which was 
applied in the in vivo infection model.
Growth curves from in vitro studies are presented as bacterial counts as a function of time in Fig. 2a, and as 
OD600 values as a function of time in Fig. 2b, respectively. Exponential growth was observed between the initial 
sampling time point and approximately 6 hours of incubation, after which growth progressively ceased towards 
stationary phase. The mass doubling time (τ) inferred from mean OD600 measurements during exponential 
growth was 25 minutes. No growth reduction due to transgene insertions in ALO 4783 was observed (Fig. 2b).
The two methods for detection of chromosome replication status (ori:terqPCR and ori:termic) were in good agree-
ment (Supplementary Fig. S1). ori:terqPCR and ori:termic followed growth rate (Fig. 2a, Supplementary Table S1). 
We observed a rapid increase in ori:ter during the first 4 hours, followed by a gradual decline as the cells stopped 
growing by 8 hours; remaining unchanged at 10 hours of incubation. In accordance with these findings, single-cell 
fluorescence microscopy analysis of oriC/cell and cell size (µm) confirmed a shift from a homogenous bacterial 
population dominated by non-growing, small cells at 0 hours (i.e. the inoculum; oriC/cell ~1), to a heterogeneous 
population dominated by bacterial cells with ongoing chromosome replications at various levels (oriC/cell ≥ 2) 
and various cell sizes at 2 hours of incubation (Fig. 3). Starting from 4 hours of incubation, a tendency towards 
more growth homogeneity was observed. At this time point, an oriC/cell of 4 was observed in approximately 80 
percent of the population, reflecting close to balanced growth (Fig. 3). Here, criteria for inferring mass doubling 
time (τ) from ori:ter were met, and τ was computed from equation (2) as (median (IQR)) 23.4 (21.5–29.9) min-
utes (assuming a constant C period of 40 minutes)25. Almost no overlapping rounds of replication were observed 
starting from 6 hours of incubation (oriC/cell ≤ 2). At 8 and 10 hours of incubation homogenous populations 
of small bacterial cells harbouring predominantly one copy of oriC/cell were observed (Fig. 3). The correlation 
between oriC/cell and cell size (µm) was very strong (r = 0.92, p < 0. 01) (Fig. 2c).
A slow-down of growth was initiated between 4 and 6 hours of incubation, during which period we observed a 
decrease in both oriC/cell and ori:ter, manifesting cessation of chromosome replication (Fig. 2a,c). As expected1, 
cell division proceeded for some time longer, as demonstrated both by the bacterial count increase and cell size 
decrease (Fig. 2a,c). Eventually, no new initiations of chromosome replication took place during stationary phase 
(8–10 hours of incubation). Inferring τ from ori:ter for time points later than 4 hours of incubation would be 
deceptive, given that the growth was too slow (i.e. the criteria of τ < 60 minutes was not met).
We can conclude that, when these bacterial cells were growing fast the ori:ter and oriC/cell ratios were high 
and cell sizes were large, and when cells were growing slowly the ori:ter and oriC/cell ratios were low and cell sizes 
were small. Our findings are consistent with the existence of a fixed initiation mass at all in vitro growth rates, 
exemplified by the good correlation between oriC/cell and cell length (Fig. 2c). These data are consistent with pre-
vious studies that have shown correlation between ori:ter and initiation mass in E. coli K-12 strain MG1655 under 
various growth conditions in vitro29. At mid-exponential phase (4 hours of incubation; Fig. 2a) a mass doubling 
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time (τ) could be inferred from ori:ter and was similar to that inferred from OD600 measurements; approximately 
23 and 25 minutes, respectively.
Bacterial growth in vivo: mouse peritonitis model. Bacterial growth dynamics at separate anatomical 
sites during widespread bacterial infection were evaluated in the model of lethal peritonitis in mice, aiming both 
to validate the ori:ter method for use in vivo, and to determine any potential growth rate differences within and 
outside the primary site of infection.
An intraperitoneal (i.p.) dose of 1 × 106 CFU/ml stationary phase bacteria (ALO 4783) resulted in the estab-
lishment of septicaemia in a total of 51/51 animals within 2 hours of infection. Samples (peritoneal lavage fluid 
(PLF), blood, spleen and kidneys) were collected in biological triplicates at time points 2, 4, 6, 8 and 10 hours of 
infection. After 10 hours of infection animals demonstrated signs of distress to such an extent that criteria for 
euthanasia were met. Thus, this constituted the final possible sample collection time point in this model. Bacterial 
DNA and live bacterial cells were successfully isolated from PLF and blood for qPCR and microscopy analysis, 
respectively. Unfortunately, we were unable to adequately isolate bacterial DNA or live bacterial cells for the above 
mentioned analyses from spleen and kidneys. Consequently, the PLF and blood bacterial populations constituted 
representative populations of bacteria growing within and outside of the primary site of infection, respectively. 
It has previously been hypothesised that bloodstream bacterial populations represent a passive ‘spill-over’ of 
bacteria from the primary site of infection, rather than independently growing populations30. Using chromosome 
replication as readout for in situ bacterial growth rate, we aimed at improving insight into whether these popula-
tions truly differ or not.
Pooled bacterial count data from repeated in vivo experiments demonstrated that the net size of the bacterial 
populations found outside the primary site of infection (i.e. bloodstream, spleen or kidneys) increased in parallel 
with the bacterial population at the primary site of infection (i.e. peritoneum) (Fig. 4a). For all collected speci-
mens (PLF, blood, spleen and kidneys) a pronounced increase in bacterial count was observed from 0 to 8 hours 
of infection, indicating bacterial growth. There was no apparent lag phase, however, this cannot be ruled out since 
Figure 1. Visualisation of intracellular oriC foci (green) and terC foci (red) by fluorescence microscopy in ALO 
4783 (shown in phase contrast) growing at various growth rates; from rapid (bottom) to slow (top) growth. 
Scale bar is 2 µm.
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no measurements were made prior to 2 hours of infection. Linear regression analysis derived slopes (β) for growth 
in blood, spleen and kidneys revealed no significant difference from growth in PLF (p > 0.05), whereas the blood, 
spleen and kidney bacterial counts differed significantly from the PLF bacterial count (p < 0.0001); meaning that 
bacterial population sizes outside the PLF were smaller, yet increasing in parallel with the PLF bacterial popu-
lation (Fig. 4a). Also, attention should be drawn to the fact that the bacterial count found at the primary site of 
infection was under-estimated. The PLF bacterial count was in reality substantially higher than reported, taken 
into consideration the dilution factor from the required addition of lavage fluid during harvesting (see Methods). 
From 8 to 10 hours of infection the net bacterial count was stagnant (Fig. 4a).
The maximum ori:terqPCR (mean (SD)) measured in vivo (2.50 (0.36) in PLF) was lower than the maxi-
mum ori:terqPCR measured in vitro (3.13 (0.55)), accounting for an overall slower growth in vivo (Figs 4b and 
2a, Supplementary Table S1). Nevertheless, ori:ter followed overall growth rate in vivo (Fig. 4b, Supplementary 
Table S1). In the PLF ori:terqPCR increased rapidly during the first 2 hours, followed by a slight decline towards 
unchanged levels at 4 and 6 hours of infection. After 6 hours of infection a gradual decline towards an ori:terqPCR 
approaching 1 was observed (Fig. 4b, Supplementary Table S1). In the blood, ori:terqPCR did not change between 4 
and 8 hours. However, no significant difference (p > 0.05) in ori:terqPCR were found between PLF and blood, when 
compared both overall by linear regression analysis and time-point by time-point (2 to 10 hours of infection) 
(Fig. 4b).
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Figure 2. Bacterial growth in LB batch cultures (in vitro). (a) Bacterial growth measured as bacterial counts 
(log10 CFU/ml), ori:terqPCR and ori:termic. ATCC 25922 and ALO 4783 were tested in parallel and showed 
similar growth; hence, results from both strains are pooled in the data sets. Bland-Altman agreement 
between ori:terqPCR and ori:termic was good (Supplementary Fig. S1). 6 h, n = 12; all other time points, n = 6. 
(b) Comparisons of ATCC 25922 and ALO 4783 grown in LB batch cultures (in vitro) revealed no growth 
retardation due to transgene insertions. Growth measured as OD600. Both strains exerted doubling times of 
25 minutes during exponential growth. (c) Bacterial cell length (µm) (used as proxy for cell mass) correlate with 
oriC/cell. Data represent pooled microscopically detected cells (ALO 4783). n = 500 at all time points, with the 
exception of 2 h, where n = 147. Data are presented as mean ± SD. Dotted line represents the limit of detection 
for bacterial count measurements. Time (h) represents hours of incubation; inoculum is presented as 0 h. r: 
Pearson’s correlation coefficient.
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There was no significant difference (p > 0.05) in oriC/cell or cell size (µm) between PLF and blood bacterial 
populations, compared at 6, 8 and 10 hours of infection (Fig. 4c). At 2 and 4 hours of infection, the total number 
of microscopically detected live bacterial cells from the blood was too low. Hence, these data are not included 
in statistical analyses or illustrations (Supplementary Table S1, Figs 4c and 5). oriC/cell and cell size (µm) data 
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Figure 3. Relative frequency distributions (%) of pooled microscopically detected bacterial cells (ALO 4783) 
from growth in LB batch cultures (in vitro); cell length (µm) (left panel) and oriC/cell (right panel). n = 500 at 
each time point, with the exception of 2 h, where n = 147. Time (h) represents hours of incubation. For oriC/
cell histograms, note that data are presented as detected by automated foci quantification, which is subject to the 
risk of underestimation due to co-localising oriCs48. Hence, it is likely that 3 detected foci truly represent 4 foci 
and that >4 detected foci truly represent 8 foci (see Methods).
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demonstrated a shift from a nearly homogenous bacterial population dominated by non-growing, small cells at 
0 hours (i.e. the inoculum; oriC/cell ~1), to heterogeneous populations dominated by bacterial cells with ongoing 
chromosome replications at various levels (oriC/cell ≥ 2) and various cell sizes at 2 (PLF only), 4 (PLF only), 
6 hours of infection (PLF and blood) (Figs 5 and 6). A minor decline in both oriC/cell and cell size was seen at 
8 hours, and was even more pronounced at 10 hours of infection. However, unlike during stationary phase in vitro, 
we did not observe a complete cessation of chromosome replication during the length of infection. At 10 hours of 
infection (where minimal oriC/cell and cell size were observed) PLF and blood oriC/cell were significantly differ-
ent from inoculum oriC/cell (p < 0.0001) (Figs 5 and 6). This indicated that fractions of the population were still 
growing, albeit slowly, at the terminal stage of infection. It has previously been reported, however, that bacteria 
may cease growth with 2 oriC/cell present31. Yet, under such conditions, ori:ter would go toward 1 (i.e. 2 fully 
replicated chromosomes), which we do not observe here.
The correlation between oriC/cell and cell size (µm) was very strong, both in PLF (r = 0.95, p < 0.01) and 
blood (r = 0.98, p < 0.05) bacterial populations (Fig. 4c).
In summary, when net population size was increasing, indicating growth, oriC/cell and ori:ter were high, and 
cell sizes were large (0–6 hours of infection) (Fig. 4b,c). After 6 hours of infection growth was gradually beginning 
to slow down, demonstrated by a slight decrease in both oriC/cell, ori:ter and cell size (µm). The data indicate the 
presence of a fixed initiation mass, also during infection in vivo. Unlike during growth in vitro, we did not observe 
a complete cessation of chromosome replication in vivo (oriC/cell and ori:ter remained >1 at all times during 
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Figure 4. Bacterial growth (ALO 4783) in the mouse peritonitis model (in vivo). (a) Bacterial growth measured 
as bacterial counts (log10 CFU/ml) in peritoneal lavage fluid (PLF), blood, spleen and kidneys: 2 h, n = 15; 4 h, 
n = 9; 6 h, n = 6; 8 h, n = 12; 10 h, n = 9. Slopes (β) from linear regression analysis (0–8 h; blood, spleen and 
kidneys versus PLF) were not significantly different (p > 0.05), yet elevations (blood, spleen and kidneys versus 
PLF) were all significantly different (p < 0.0001) (b) Bacterial growth measured as bacterial counts, ori:terqPCR 
and ori:termic in PLF and blood. PLF bacterial count and ori:terqPCR: 2 h, n = 15, 4 h, n = 9; 6 h, n = 6; 8 h, n = 12; 
10 h, n = 9. Blood bacterial count: 2 h, n = 15, 4 h, n = 9; 6 h, n = 6; 8 h, n = 12; 10 h, n = 9. Blood ori:terqPCR: 
2 h, n = 12; 4 h, n = 8; 6 h, n = 5; 8 h, n = 12; 10 h, n = 9. ori:termic from 2 and 4 h (blood) are not presented due 
to insufficient number of microscopically detected cells (Supplementary Table S1). Bland-Altman agreement 
between ori:terqPCR and ori:termic was good (Supplementary Fig. S1). (c) Bacterial cell length (µm) (proxy for 
cell mass) correlate with oriC/cell, both in PLF and blood. Data represent pooled microscopically detected cells. 
Inoculum (0 h), n = 500. PLF: 2 h, n = 133; 4 h, n = 55; 6 h, n = 132; 8 h & 10 h, n = 500. Blood: 6 h, n = 164; 8 h, 
n = 157; 10 h, n = 500; 2 h and 4 h time points are not presented due to insufficient number of cells. Data are 
presented as mean ± SD. Dotted line represents the limit of detection for bacterial counts. Time (h) represents 
hours of infection; inoculum is presented as 0 h and extrapolated to PLF data. r: Pearson’s correlation coefficient.
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the course of the experiment) (Figs 4b, 5 and 6 and Supplementary Table S1). As demonstrated by the persistent 
growth heterogeneity (i.e. unbalanced growth), inferring τ from ori:ter during growth in vivo would be deceptive 
(Figs 5 and 6). However, ori:ter, as demonstrated, may be used as an independent measure of bacterial growth rate 
during infection in vivo.
Bacterial growth in vivo: mouse intravenous (i.v.) septicaemia model. To determine whether the 
bacterial population found in the bloodstream during peritonitis represented cells growing independently of that 
at the primary site of infection or not, we attempted to induce primary septicaemia directly via i.v. inoculation of 
1 × 106 CFU/ml bacteria (ALO 4783). We were unable to establish an infection, as a complete clearance of bac-
teria from the bloodstream had occurred prior to the initial sample collection time point; 2 hours post bacterial 
challenge (Supplementary Fig. S2). No viable bacterial counts were found in blood, PLF or kidneys at any time. 
However, in the spleen we observed the presence of a stable bacterial population of (mean (SD)) 3.41 (0.03) log10 
CFU/ml of all animals at all times (2–8 hours post challenge), likely as a result of bacterial bloodstream clearance.
None of the animals presented any signs of distress during the observation period, in contrary to the mouse 
peritonitis model, where signs of distress were starting to appear from 2 hours of infection.
Discussion
We have applied and validated two well-established methods for detection of bacterial chromosome replication 
to shed light on fundamental growth dynamics of E. coli during infection in vivo. ori:ter was determined by 
qPCR and fluorescence microscopy, respectively, overall with good agreement between methods. The microscopy 
method has the advantage that it allows for direct observation of in situ ori:ter at a single-cell level, which can 
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Figure 5. Relative frequency distributions (%) of pooled microscopically detected bacterial cells (ALO 4783) 
isolated from blood in the mouse peritonitis model; cell length (µm) (left panel) and oriC/cell (right panel). 
Inoculum, n = 500; 6 h, n = 164; 8 h; n = 157; 10 h, n = 500. Data from 2 and 4 h are not presented, due to 
insufficient number of microscopically detected cells (Supplementary Table S1). Time (h) represents hours of 
infection.
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be used to observe the level of replication heterogeneity within a bacterial population. Also, microscopy can be 
used to determine cell size, which demonstrated good correlation with the number of replication origins (oriC/
cell), in agreement with initiation of chromosome replication taking place at a fixed initiation mass under all 
growth conditions. However, the fluorescence microscopy method requires precedent fluorescent labelling at 
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Figure 6. Relative frequency distributions (%) of pooled microscopically detected bacterial cells (ALO 4783) 
isolated from peritoneal lavage fluid (PLF) in the mouse peritonitis model; cell length (µm) (left panel) and 
oriC/cell (right panel). Inoculum, n = 500. PLF: 2 h, n = 133; 4 h, n = 55; 6 h, n = 132; 8 h, n = 500; 10 h, n = 500. 
We emphasize that data representing 4 hours of infection are subject to uncertainty, due to low number of 
detected cells (n < 100). Time (h) represents hours of infection.
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relevant chromosome loci, along with a certain bacterial quantity for cells to be detected, which is a limitation to 
the method. The qPCR method, by contrast, reports only the mean ori:ter of a population, without regard to any 
possible heterogeneity. However, this method is less time consuming, uncomplicated and inexpensive, compared 
to whole genome sequencing. We conclude that both qPCR and fluorescence microscopy are valid methods for 
measuring in situ bacterial growth during infection, and that they complement each other favourably.
Bacterial growth in a closed batch-culture in vitro was shown to be directly related to nutrient availability, as 
anticipated32,33. Ori:ter levels were high, with a high level of replication heterogeneity, during the first hours of 
incubation. Subsequently, as the bacterial count increased, we observed a complete cessation of growth within a 
homogenous population of predominantly non-replicating cells, due to starvation after prolonged propagation33. 
A similar pattern of growth was observed in vivo during infection in the mouse peritonitis model. However, 
unlike during growth in vitro, we observed no complete cessation of growth in neither PLF nor blood as the bac-
terial densities reached their maximum in the terminal stage of infection. At this stage (8 to 10 hours of infection), 
the stagnant development in bacterial count is deceptive, as it gives the perception of growth cessation. Indeed, a 
complete cessation of growth might never occur during infection in vivo, where bacterial life-sustaining resources 
presumably are still available as long as the animal is alive. We show in this model that the apparent stationary 
phase during infection represents fractions of both slowly growing and non-growing cells, conceivably balanced 
by cells taken out by the host immune system. Hence, it is evident that one cannot extrapolate findings from in 
vitro growth studies to explain pharmacodynamics in relation to bacterial growth during infection in vivo, par-
ticularly not in regard to the apparent stationary phase. The in vitro effect of most commonly used antibiotics, 
including β-lactams, fluoroquinolones and aminoglycosides, has been shown to correlate to bacterial growth 
rate26,27. Chromosome replication as a readout for bacterial growth rate could form the basis for refined future 
studies on antibiotic treatment effect as a function of bacterial growth rate during infection in vivo.
In the mouse peritonitis model, significantly lower bacterial count densities could be found in the blood, rel-
ative to the PLF, yet ori:ter and oriC/cell remained similar in blood and PLF. These findings, taken together with 
the observed inability of the same strain to establish an infection upon direct introduction into the bloodstream 
(as demonstrated by the i.v. septicaemia model), suggest that E. coli found outside the primary site of infection 
(e.g. in the bloodstream) is not constituted by an independently growing population, but rather mirrors the pop-
ulation found at the primary site of infection. This is in consistence with previous in vivo studies of Streptococcus 
pneumoniae in the same experimental model, describing the phenomenon as ‘spill-over’30. Conceivably, bacterial 
cells grow at a given rate at the primary site of infection (e.g. the peritoneal cavity), followed by a translocation 
through lymphatic drainage into the systemic venous system via the thoracic duct and onward to relevant tissues, 
such as the spleen and kidneys where bacterial phagocytic clearance and filtration, respectively, take place11,34. 
Our findings are in accordance with previous studies indicating that E. coli, unlike bacteria such as Haemophilus 
influenzae, do not grow independently intravascularly8,35,36. Our data suggest that bacterial cells surviving in 
the bloodstream remain within the same state of growth as that of bacterial cells at the primary site of infection, 
without acceleration or significant deceleration; likely as the net result of constant influx- and kill-rate of bacteria. 
These findings underscore the importance of source control in septicaemia, i.e. locating and ensuring antibiotic 
availability at the primary site of infection, as this is where active bacterial growth is taking place.
In conclusion, we present data supporting the applicability of both qPCR and fluorescence microscopy as valid 
methods for determination of bacterial growth rate in vivo. The methods could be extrapolated to other infection 
models and other pathogenic bacteria. Ultimately, it would be evident to pursue the inexpensive and easily acces-
sible qPCR method in a clinical setting to examine bacterial growth rates in infected body fluids, which could 
prove helpful in evaluating future antibacterial strategies.
Methods
Bacterial strains and inoculum preparations. Escherichia coli ATCC® 25922™, a clinical isolate from 
the American Type Culture Collection (Manassas (VA), USA) and CLSI and EUCAST control strain for antibiotic 
susceptibility testing, was used throughout the study. This strain was applied in vitro both as a wild-type and as a 
genetically modified version expressing fluorescent fusion-proteins at chromosomal sites corresponding to oriC 
and terC, respectively (ALO 4783). Only ALO 4783 was applied in the in vivo models.
For in vitro experiments, inoculum from frozen stock cultures were grown overnight in Lysogeny Broth (LB) 
broth, shaking 140 rpm, at 37 °C in ambient air. Bacterial counts were quantified by spotting 10 µl of 10-fold serial 
dilutions made in sterile physiological saline in duplicate on LB agar plates.
For in vivo experiments, bacteria were grown from frozen stock cultures overnight at 35 °C in ambient air 
on 5% blood agar plates (SSI Diagnostica, Copenhagen, Denmark), after which inocula were suspended in ster-
ile physiological saline and quantified by measurement of optical density at 546 nm (OD546). Porcine mucin 
(M-2378, Sigma-Aldrich, Munich, Germany) was added as adjuvant to a final concentration of 5% (wt/vol). The 
mucin stock solution was prepared in physiological saline, sterilised and adjusted to physiological pH before 
application. The final inoculum (106 CFU/ml) was quantified by spotting 20 µl of serial dilutions in duplicate on 
selective bromothymol lactose blue agar plates (SSI Diagnostica, Copenhagen, Denmark).
Construction of double-loci fluorescent-labelled strain. For microscopic visualisation of cellular ori-
gins and termini, transgenes were inserted into the ATCC 25922 chromosome, by use of the lambda red recombi-
neering technique previously described37,38. P1parS::KAN was PCR amplified from plasmid pMS2438 and inserted 
into the chromosome in the oriC region by use of lambda red recombineering plasmid pTP22339, using primers 
5′-CATCATTAAAGTGCTGTACCGTAACTAACAGAAAGGCCTTAAAGCCGAAGCCTTAAACTT-3′ and 
5′-GGGTTAATAGCGATTCAGAGTTCAAGGCCTTCTCCCGGAGGGAACTTCAAGATCCCCTTA-3′. Also, 
pMT1parS::CHL was PCR amplified from plasmid pGBkD3-parSpMT138 and inserted, by the same method, into 
the chromosome in the terC region using primers 5′- ATATAAATTCTATAATTAGATGTATCTTTCCAT 
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TTACGGCGTGTAGGCTGGAGCTGCTTC-3′ and 5′- TCGGTGTGAGATGCTTTACGTCTTCCAAGCCCC 
CTTCCTTCGTCTTACTGTCGGGAATTC-3′.
Furthermore, the pTrc-mCherry-pMTparB-GFP-P1parB cassette was PCR amplified from pJFM440 and 
inserted into the chromosomal attTN7 site at the 3′ end of the glmS gene, using the protocol for Tn7 transgene 
insertion as previously described41, resulting in strain ALO 4783. Co-expression of GFP-labelled P1-ParB proteins 
and mCherry-labelled pMT-ParB proteins29 in live cells allowed for visualisation of origins as GFP foci (green) 
and termini as mCherry foci (red), respectively. Correct insertion of all transgenes was confirmed by PCR.
It should be noted that a substantial part of the LacI operator on pRN01042, from which the pTrc-mCherry- 
pMTparB-GFP-P1parB cassette on pJFM4 originated, had unintentionally been lost during plasmid construction. 
Thus, the use of IPTG (isopropyl β-D-1-thiogalactopyranoside) for induction of the fluorescence fusion proteins 
proved redundant.
In vitro experiments. Overnight liquid cultures of both wild-type and genetically modified version of 
ATCC 25922 with a bacterial density of 109 CFU/ml were diluted 1:10,000 into fresh media and grown with 
shaking 140 rpm, at 37 °C.
Growth was observed by repeated measurements of optical density at 600 nm (OD600). Samples for quanti-
fication of bacterial count, qPCR analysis and fluorescence microscopy were withdrawn at time points 2, 4 and 
6 hours of incubation in the exponential growth phase study, and at times 6, 8 and 10 hours of incubation for 
the stationary growth phase study, respectively. All samples were immediately set on ice after withdrawal. Both 
studies were performed in duplicate (i.e. including both wild-type ATCC 25922 as control of growth, and the 
genetically modified version, ALO 4783) in three independent experiments. As both growth curves and ori:ter 
were the same for both versions of the strain, these results were pooled for statistical analyses. For fluorescence 
microscopy, only ALO 4783 was applied.
Experimental animal models. Mouse peritonitis model. The mouse peritonitis model has been previ-
ously described and studied extensively43,44. Here, outbred female NMRI mice (BomTac: NMRI; weight 26–30 g; 
Taconic, Denmark) were applied throughout the study. The animals were kept in Macrolon type III cages in 
groups of three and allowed free access to feed and water. Experiments were initiated after an acclimatisation 
period of 5 days.
Inoculation was performed by intraperitoneal (i.p.) injection of 0.5 ml bacterial suspension containing 106 CFU/ml 
and 5% (wt/vol) mucin. At various time points of infection, the mice were anaesthetized with a subcutaneous 
(s.c.) injection of pre-mixed Zolazepam/Tiletamin (Zoletil, Virbac, Kolding, Denmark), Xylasin (Xysol Vet., 
ScanVet, Fredensborg, Denmark) and Butorphanol (Torbugesic Vet inj., Orion Pharma, Copenhagen, Denmark) 
prior to blood collection from total cardiocentesis, performed with a 30-gauge needle via subxiphoid access. 
Blood was stored in EDTA covered micro tubes (Sarstedt, Nümbrecht, Germany). After euthanasia by cervical 
dislocation, a peritoneal lavage was performed by injecting 2.0 ml of sterile physiological saline i.p. After 1 minute 
of abdominal massage, the peritoneum was opened and peritoneal lavage fluid (PLF) withdrawn with a pipette. 
Spleen and both kidneys were surgically removed using sterile procedures and placed in Eppendorf tubes.
All specimens were immediately placed in an insulated 4 °C cooling box for transportation and kept on ice at 
4 °C until application in subsequent tests. Standard bacterial quantification and DNA purification were performed 
within two hours; fluorescence microscopy the subsequent day. To ensure that bacterial cells in the blood and PLF 
specimens did not undergo any alterations in any of the growth parameters measured (ori:ter, oriC/cell or cell 
size) while kept on ice at a non-permissive growth temperature45 post harvesting, we performed a confirmatory in 
vitro experiment where chromosome replication analyses (qPCR and fluorescence microscopy) were performed 
on exponentially growing cells left on ice for up to 24 hours (Supplementary Materials). The results combined 
confirmed that storage up to 24 hours on ice at non-permissive growth temperatures did not alter these parame-
ters (Supplementary Fig. S3).
The mouse peritonitis model was repeated in a total of 6 independent experiments, where groups of three 
cohabitant animals were sacrificed at various combinations of time points; 2 (n = 15), 4 (n = 9), 6 (n = 6) 8 
(n = 12) or 10 (n = 9) hours of infection.
Data from repeated experiments were pooled for statistical analyses.
Mouse intravenous septicaemia model. To examine the possibility of inducing primary bacteraemia without an 
established infection outside of the bloodstream, we applied a direct intravenous (i.v.) septicaemia mouse model. 
Mice, housing, acclimatisation and feeding procedures were identical to that of the mouse peritonitis model. 
However, here, the mice were inoculated via i.v. injection of 0.2 ml bacterial suspension containing 106 CFU/
ml, without adjuvant, into the lateral tail vein. Animals were subsequently handled as above mentioned, with 
the extraction of blood, peritoneal wash fluid, spleen and kidneys, which were all kept at 4 °C after harvesting. 
The animals were sacrificed in groups of three biological replicates at 2 (n = 3), 4 (n = 3) and 8 (n = 3) hours of 
infection.
Ethics statement. Mice in both experimental models were regularly observed and scored for signs of distress. 
Humane end points were constituted by signs of irreversible sickness. The mice would be euthanized upon pres-
entation of any of these signs. All animal experiments were approved by the Danish Animal Experimentation 
Inspectorate (Licence No. 2014-15-0201-00171) and performed according to institutional guidelines.
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Quantification of bacterial growth. Samples from in vitro experiments were spotted (10 µl) in duplicate 
of serial dilutions on LB agar plates, and the bacterial count was recorded as the mean of two plates after overnight 
incubation at 37 °C in ambient air. The detection limit was 100 CFU/ml.
To the tubes containing spleen or kidneys from the in vivo experiments, sterile physiological saline was 
added to a total volume of 1 ml, after which they were homogenised for 2 minutes at 30 oscillations/sec using a 
TissueLyser II (Qiagen, US), before being spotted (20 µl) in serial dilutions in duplicate on bromothymol lactose 
blue agar plates. The required addition of saline before homogenisation of the tissues entailed a dilution factor 
of approximately 1:1. Blood and peritoneal wash fluid from in vivo experiments were spotted directly, without 
further dilution. Colony counts were performed after overnight incubation at 35 °C in ambient air and recorded 
as the mean of two plates. The detection limit for blood specimens was 50 CFU/ml. The other materials were 
recorded as CFU/ml of solution.
Quantitative PCR (qPCR). ori:terqPCR was calculated as the population mean level of qPCR amplified oriC 
to terC, respectively.
Samples from in vitro experiments were prepared by pelleting 1 ml of culture by 5 min centrifugation at 
15,0000 × g, after which bacterial cells were re-suspended in 100 µl 10 mM Tris pH 7.4 and 900 µl 77% Ethanol 
and kept at 4 °C until qPCR was performed. Here, cells were spun down and re-suspended in serial dilutions of 
sterile DNA/RNA free water prior to analysis.
Bacterial DNA from blood and peritoneal lavage fluid from in vivo experiments were purified for qPCR using 
QIAamp DNA Mini Kit (51304, Qiagen, Hilden, Germany), according to the manufacturer’s instructions. We 
were unable to purify adequate quantities of bacterial DNA from spleen and kidney tissue for use in this analysis, 
possibly due to co-purification of murine DNA and/or low bacterial counts in the tissues.
qPCR was performed as previously described, using primers 5′-CGCAACAGCATGGCGATAAC-3′ and 
5′-TTCGATCACCCCTGCGTACA-3′ for partial amplification of the highly conserved gidA gene located imme-
diately leftwards of oriC (representing the oriC region), and primers 5′-TCAACGTGCGAGCGATGAAT-3′ and 
5′-TTGAGCTGCGCTTCATCGAG-3′ for partial amplification of the dcp gene, located in close proximity to 
terC, opposite the oriC region (representing the terC region), respectively28.
The analysis was performed using Takara SYBR Premix Ex Taq II (RR820A, Takara Bio, 
Saint-Germain-en-Laye, France) in a BioRAD CFX96 (95 °C 30 s, 39 × (95 °C 5 s + 58 °C 30 s), 95 °C 15 s, 60 °C 
60 s, 95 °C −15 s, 65 °C −5 s, 95 °C − ∞), as previously reported40. The ori:terqPCR was calculated using compara-
tive cycle threshold (Ct) analysis; the 2∆∆Ct method46. A fixed sample of the same strain grown into late stationary 
phase, where the population would be expected to have an ori:ter corresponding to 1, was used for normalisation 
in every cycling run.
Each biological replicate was run as a minimum as three technical replicates in each cycling run, and the mean 
Ct value of the technical triplicates (or more) was used to calculate the ori:terqPCR. DNA/RNA-free water was used 
as negative control template in each run. Furthermore, QIAamp PCR purified blood and peritoneal lavage fluid 
specimens without viable bacterial growth were regarded as negative controls for blood and peritoneal lavage 
fluid derived specimens. There was a qPCR detection limit corresponding to approximately 103 CFU/ml for puri-
fied blood specimens. Hence, not all purified blood specimens yielded adequate qPCR results. No detection limit 
was observed in samples from in vitro experiments.
Fluorescence microscopy. ori:termic was calculated from automated photomicrographic detection of pooled 
single bacterial cells carrying intracellular fluorescent markers corresponding to oriC and terC, respectively.
For phase contrast and fluorescence microscopy, bacterial cells were spun down for 2 minutes at 6,000 × g, 
re-suspended in a small volume of AB minimal medium47 and mounted on microscope slides covered with a thin 
2% (wt/vol) AB minimal medium agarose pad.
Blood specimens from in vivo studies underwent murine cell lysis prior to pelleting, by the addition of cold, 
sterile water mixed with the sample at a ratio of approximately 1:1 for 1 minute. Harvested tissues were not 
observed in the microscope.
A total of 500 live bacterial cells were pooled and analysed from each time point, with the exception of certain 
specimens, where this was not possible due to the quantity of live cells available for microscopy detected being 
too low (Supplementary Table S1). The ori:termic was deduced from the mean of oriC foci detected divided by the 
mean of terC foci detected.
It should be noted that fractions of the bacterial cells were recorded with a number oriC copies ≠ 2n (n = 1, 2, 
3). The risk of underestimation of co-localising oriCs is a known microscopy resolution limitation in photomi-
crographic foci quantification48. It is unlikely that the bacterial cells propagating in vitro underwent asynchronous 
replication initiation4. Accordingly, cells reported with an oriC/cell of 3 in all likelihood represent 4 oriC/cell, and 
cells reported with an oriC/cell > 4 in all likelihood represent 8 oriC/cell (Fig. 3). Since less is known about chro-
mosome replication during infection in vivo, we cannot rule out any possible replication initiation asynchrony in 
bacterial populations from the in vivo experiments (Figs 5 and 6).
Medial axis cell length (µm) was recorded by automated detection and used as surrogate measure for cell mass.
Images were acquired with a Zyla 5.5 sCMOS camera attached to a Nikon Eclipse Ti-E inverted microscope 
and analysed with NIS-ELEMENTS and MicrobeJ software for automated bacterial cell and fluorescent foci 
detection and quantification49.
Statistical analyses. Bacterial quantification data were log10 transformed prior to analysis. D’Agostino and 
Pearson omnibus normality test was applied to all data sets. In general, the bacterial count and the qPCR data 
sets represented a normal distribution. Cell length and numbers of oriC foci detected by microscopy did not all 
meet the assumptions for normal distribution. Linear regression analysis was used to compare bacterial counts or 
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ori:ter between different materials harvested in the in vivo experiments. Additionally, two-way ANOVA followed 
by Sidak’s multiple comparisons test was applied within the same data sets to test difference between blood and 
peritoneal ori:ter at each time point. Pearson’s correlation coefficient was applied to estimate correlation between 
cell length (µm) and oriC/cell. The Kolmogorov-Smirnov test was applied to test differences in oriC/cell distri-
butions between bacterial populations in the blood and PLF, respectively, at different time points. Bland-Altman 
analysis was performed to evaluate agreement between the qPCR and the microscopy method for detection of 
ori:ter. A two-tailed p value < 0.05 was considered significant.
GraphPad Prism version 7 (GraphPad Software, CA, USA) was applied for statistical analysis and illustration.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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